Literature DB >> 33546456

Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile.

Adam Mieczkowski1, Elżbieta Speina1, Damian Trzybiński2, Maria Winiewska-Szajewska1, Patrycja Wińska3, Ewelina M Borsuk1, Małgorzata Podsiadła-Białoskórska1, Tomasz Przygodzki4, Krzysztof Drabikowski1, Lidia Stanczyk4, Igor Zhukov1, Cezary Watala4, Krzysztof Woźniak2.   

Abstract

Phosphodiesterase 5 (PDE5) is one of the most extensively studied phosphodiesterases that is highly specific for cyclic-GMP hydrolysis. PDE5 became a target for drug development based on its efficacy for treatment of erectile dysfunction. In the present study, we synthesized four novel analogues of the phosphodiesterase type 5 (PDE5) inhibitor-tadalafil, which differs in (i) ligand flexibility (rigid structure of tadalafil vs. conformational flexibility of newly synthesized compounds), (ii) stereochemistry associated with applied amino acid building blocks, and (iii) substitution with bromine atom in the piperonyl moiety. For both the intermediate and final compounds as well as for the parent molecule, we have established the crystal structures and performed a detailed analysis of their structural features. The initial screening of the cytotoxic effect on 16 different human cancer and non-cancer derived cell lines revealed that in most cases, the parent compound exhibited a stronger cytotoxic effect than new derivatives, except for two cell lines: HEK 293T (derived from a normal embryonic kidney, that expresses a mutant version of SV40 large T antigen) and MCF7 (breast adenocarcinoma). Two independent studies on the inhibition of PDE5 activity, based on both pure enzyme assay and modulation of the release of nitric oxide from platelets under the influence of tadalafil and its analogues revealed that, unlike a reference compound that showed strong PDE5 inhibitory activity, the newly obtained compounds did not have a noticeable effect on PDE5 activity in the range of concentrations tested. Finally, we performed an investigation of the toxicological effect of synthesized compounds on Caenorhabditis elegans in the highest applied concentration of 6a,b and 7a,b (160 μM) and did not find any effect that would suggest disturbance to the life cycle of Caenorhabditis elegans. The lack of toxicity observed in Caenorhabditis elegans and enhanced, strengthened selectivity and activity toward the MCF7 cell line made 7a,b good leading structures for further structure activity optimization and makes 7a,b a reasonable starting point for the search of new, selective cytotoxic agents.

Entities:  

Keywords:  PDE5 inhibitor; cytotoxicity; diketopiperazine; short peptide; tadalafil

Mesh:

Substances:

Year:  2021        PMID: 33546456      PMCID: PMC7913621          DOI: 10.3390/molecules26040794

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  52 in total

Review 1.  Developments around the bioactive diketopiperazines: a patent review.

Authors:  Yi Wang; Pei Wang; Hongguang Ma; Weiming Zhu
Journal:  Expert Opin Ther Pat       Date:  2013-08-21       Impact factor: 6.674

Review 2.  Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses.

Authors:  Zhufeng Peng; Lu Yang; Qiang Dong; Qiang Wei; Liangren Liu; Bo Yang
Journal:  Urol Int       Date:  2017-06-21       Impact factor: 2.089

3.  Design and in Vitro Characterization of Tricyclic Benzodiazepine Derivatives as Potent and Selective Antileukemic Agents.

Authors:  Adam Mieczkowski; Tomasz Frączyk; Mateusz Psurski; Patrycja Wińska; Paweł Siedlecki; Monika Dziełak; Damian Trzybiński; Marcin Wilczek; Maciej Bagiński; Bartosz Bieszczad; Krzysztof Woźniak
Journal:  Chem Biodivers       Date:  2020-12-30       Impact factor: 2.408

4.  Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective.

Authors:  Ashraf H Abadi; Bernard D Gary; Heather N Tinsley; Gary A Piazza; Mohammad Abdel-Halim
Journal:  Eur J Med Chem       Date:  2010-04       Impact factor: 6.514

5.  Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.

Authors:  Nermin S Ahmed; Bernard D Gary; Hethar N Tinsley; Gary A Piazza; Stefan Laufer; Ashraf H Abadi
Journal:  Arch Pharm (Weinheim)       Date:  2010-12-22       Impact factor: 3.751

Review 6.  Tadalafil for the treatment of pulmonary arterial hypertension.

Authors:  Erika B Rosenzweig
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 7.  Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.

Authors:  Matthew A Cantrell; Jordan Baye; Scott Martin Vouri
Journal:  Pharmacotherapy       Date:  2013-03-25       Impact factor: 4.705

8.  Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

Authors:  Paolo Serafini; Kristen Meckel; Michael Kelso; Kimberly Noonan; Joseph Califano; Wayne Koch; Luigi Dolcetti; Vincenzo Bronte; Ivan Borrello
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

9.  Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe).

Authors:  Jessica C Hassel; Huanhuan Jiang; Carolin Bender; Julia Winkler; Alexandra Sevko; Ivan Shevchenko; Niels Halama; Antonia Dimitrakopoulou-Strauss; Walter E Haefeli; Dirk Jäger; Alexander Enk; Jochen Utikal; Viktor Umansky
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more
  4 in total

1.  Advances in Research of Short Peptides.

Authors:  Joanna Bojarska
Journal:  Molecules       Date:  2022-04-11       Impact factor: 4.927

2.  New Advances in Short Peptides: Looking Forward.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Tsun-Thai Chai; Jack Feehan; Krzysztof Kaczmarek; John M Matsoukas; Octavio Paredes Lopez; Michele Saviano; Mariusz Skwarczynski; Jillian Smith-Carpenter; Mariano Venanzi; Wojciech M Wolf; Piotr Zielenkiewicz; Zyta M Ziora
Journal:  Molecules       Date:  2022-06-06       Impact factor: 4.927

Review 3.  Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.

Authors:  Joanna Bojarska; Adam Mieczkowski; Zyta M Ziora; Mariusz Skwarczynski; Istvan Toth; Ahmed O Shalash; Keykavous Parang; Shaima A El-Mowafi; Eman H M Mohammed; Sherif Elnagdy; Maha AlKhazindar; Wojciech M Wolf
Journal:  Biomolecules       Date:  2021-10-14

Review 4.  Diketopiperazine Gels: New Horizons from the Self-Assembly of Cyclic Dipeptides.

Authors:  Marco Scarel; Silvia Marchesan
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.